Contact Us
Senior Vice President, Content
Contact members of the content team with article submissions, questions, and comments at:
Vice President, Content
Editorial Director
Managing Editor
Editor
Assistant Editor
Operations
Director of Circulation
For general inquiries:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Pirtobrutinib Gains FDA Approval for Frontline CLL/SLL in Select Patients
2
Ubamatamab Shows Durable Responses in Low-Grade Serous Ovarian Cancer
3
NDA Submission Initiated for Zipalertinib Combo in EGFR Exon 20+ NSCLC
4
What Stood Out at IMS 2026? Five Myeloma Experts Weigh In
5